Stay updated on Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial
Sign up to get notified when there's something new on the Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial page.

Latest updates to the Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial page
- Check3 days agoChange DetectedIntroduced a government funding status notice and a new site revision tag (v3.4.1); the previous revision tag (v3.4.0) was removed.SummaryDifference0.8%

- Check10 days agoChange DetectedThe page history now shows the glossary by default, uses green and red highlights for additions and deletions, and displays a new Revision: v3.4.0 label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page history shows a new Revision: v3.3.4 added and Revision: v3.3.3 removed, reflecting a minor update to version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the study record history. The references to 'HHS Vulnerability Disclosure' and the prior 'Revision: v3.3.2' note were removed.SummaryDifference0.2%

- Check53 days agoChange DetectedNew entries on 2025-12-15 indicate Results Posted and include updates to Outcome Measures (Results) and Study Status. The prior version on 2025-11-26 also shows Study Status updates.SummaryDifference0.6%

- Check68 days agoChange DetectedVersion 10 (2025-11-24) adds Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other Document Sections; it shows Quality Control Review Not Concluded and Revision: v3.3.2, while Revision: v3.3.1 was removed.SummaryDifference1%

Stay in the know with updates to Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial page.